Louisiana, like other states, grapples with widespread drug abuse. CDC’s DrugOverdose Death Data show Louisiana had a statistically significant 14.7% increase in its drug overdose death rate from 2015–2016. As early as 2013, the Louisiana Office of Public Health, Infectious Disease Epidemiology section (IDEpi), began receiving requests for drug abuse data from the governor’s office and community- based organizations for a deeper understanding of overdose trends and populations at greatest risk.
Drug Overdose
THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC ALL DRUG V2 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.
This fact sheet, developed by the Network for Public Health Law and published August 29, 2018, summarizes Ohio's laws to combat the opioid overdose crisis.
Read more about this resource at https://www.networkforphl.org/resources_collection/2018/08/29/1027/naloxone_access_and_overdose_good_samaritan_law_in_ohio?blm_aid=193546.
THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC OPIOID V3 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.
THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC HEROIN OVERDOSE V4 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.
THE KNOWLEDGE REPOSITORY HAS BEEN UPDATED TO INCLUDE CDC STIMULANT OVERDOSE V3 - THE UPDATED SYNDROME DEFINITION CAN BE FOUND HERE.
Description
The State of Ohio, as well as the country, has experienced an increasing incidence of drug ODs over the last three decades [3]. Of the increased number of unintended drug OD deaths in 2008, 9 out of 10 were caused by medications or illicit drugs [1]. In Ohio, drug ODs surpassed MVCs as the leading cause of injury death in 2007. This trend has continued through the most current available data [3]. Using chief complaint data to quickly track changes in the geographical distribution, demographics, and volume of drug ODs may aid public health efforts to decrease the number of associated deaths.
Objective:
Preliminary analysis was completed to define, identify, and track the trends of drug overdoses (OD), both intentional and unintentional, from emergency department (ED) and urgent care (UC) chief complaint data.
Description
Drug-related deaths have increased over the past decade throughout the United States. In New York City (NYC), every year there are approximately 900 psychoactive drug-related fatalities with the majority involving opioids. Unintentional drug overdose is the fourth leading cause of early adult death in NYC, and high rates of drug-related morbidity among drug users are evidenced by over 30,000 drug mentions in NYC emergency departments each year. Moreover, nonfatal overdose may be common among chronic drug users. Despite the relationship between fatal and non-fatal overdose clusters and continued increases in drug-related morbidity and mortality, no regular surveillance system currently exists. The implementation of a drug-related early warning system can inform and target a comprehensive public health response addressing the significant health problem of overdose morbidity and mortality.
Objective
This presentation describes how multiple syndromic data sources from emergency medical services ambulance dispatches and emergency department visits can be combined to routinely monitor citywide spatial patterns of adverse drug events and drug morbidity. This information can be used to target information, treatment and prevention services to drug “hotspots,” to provide early warning for drug-related morbidity, and to detect potential increased risk for overdose death.
Referenced File
Drug overdose claimed the lives of more than 63,000 Americans in 2016. The majority of these deaths, over 42,000, involved opioids such as heroin, prescription painkillers, and, increasingly, illicitly manufactured fentanyl. Indiana is not immune to this national crisis. In 2003, for example, only three Indiana residents died from heroin-related overdose. In 2016, the number was 296.
The overdose crisis continues unabated. While the epidemic was originally fueled largely by prescription opioid pain relievers, around 2010 a dramatic increase in heroin-related overdoses began. After remaining essentially stable for years, overdose deaths involving heroin spiked rapidly, more than tripling between 2010 and 2014. Starting in 2014, the epidemic began another transformation. Black market drug products—both heroin and counterfeit pills - became increasingly adulterated with illicitly—manufactured synthetic opioids, mainly fentanyl analogues.